EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

A Blind Spot in Post‐Liver Transplant Care: Correlation and Causation in Immunosuppression, Drug Monitoring, and Immune Checkpoint Inhibitor‐Related Rejection

Björn Nashan iD

Health Care Science · 2026-06 · 5 (3) · 169-173

DOI: 10.1002/hcs2.70070 ↗

Kurz gefasst

Editorial in der Zeitschrift Health Care Science, online erschienen am 16.04.2026. Verfasst von Björn Nashan. Beteiligte Einrichtung: Research Centre of Big Data and Artificial Intelligence of Medicine, The First Affiliated Hospital, Sun Yat-sen University Guangzhou China. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Research Centre of Big Data and Artificial Intelligence of Medicine, The First Affiliated Hospital, Sun Yat-sen University Guangzhou China.
  • The Transplantation Center, First Affiliated Hospital, School of Life Sciences and Medical Center, University of Sciences and Technology of China Hefei China.

ORCID-Profile: Björn Nashan

Zitieren

APA

Nashan, B. (2026). A Blind Spot in Post‐Liver Transplant Care: Correlation and Causation in Immunosuppression, Drug Monitoring, and Immune Checkpoint Inhibitor‐Related Rejection. Health Care Science, 5(3), 169-173. https://doi.org/10.1002/hcs2.70070

Vancouver

Nashan B. A Blind Spot in Post‐Liver Transplant Care: Correlation and Causation in Immunosuppression, Drug Monitoring, and Immune Checkpoint Inhibitor‐Related Rejection. Health Care Science. 2026;5(3):169-173. doi:10.1002/hcs2.70070

BibTeX
@article{Nashan2026,
  author = {Nashan, Björn},
  title = {A Blind Spot in Post‐Liver Transplant Care: Correlation and Causation in Immunosuppression, Drug Monitoring, and Immune Checkpoint Inhibitor‐Related Rejection},
  journal = {Health Care Science},
  year = {2026},
  volume = {5},
  number = {3},
  pages = {169--173},
  doi = {10.1002/hcs2.70070}
}
Kostenlos starten →